Nup54 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| NUP54 Gene | |
|---|---|
| Full Name | Nucleoporin 54 |
| Chromosome | 4p13 |
| NCBI Gene ID | 54627 |
| OMIM ID | 607607 |
| Ensembl ID | ENSG00000125787 |
| UniProt ID | Q7Z417 |
| Associated Diseases | Amyotrophic Lateral Sclerosis, Frontotemporal Dementia, Spinocerebellar Ataxia |
NUP54 (Nucleoporin 54) encodes a critical component of the nuclear pore complex (NPC), specifically forming heterodimers with NUP58 (NUP57 in yeast) to create the central transport channel of the NPC. The nuclear pore complex is essential for all nucleocytoplasmic communication, regulating the passage of proteins, RNA, and ribonucleoprotein complexes between the nucleus and cytoplasm. In neurons, where transcriptional programs are dynamically regulated by synaptic activity, proper NPC function is crucial for synaptic plasticity, local protein synthesis, and neuronal survival. NUP54 dysfunction has been implicated in amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and various spinocerebellar ataxias (SCAs).
NUP54 forms the central channel scaffold of the nuclear pore complex through heterodimerization with NUP58:
NUP54 is expressed throughout the nervous system:
High expression in regions affected in neurodegenerative diseases suggests potential involvement in disease pathogenesis.
| Disease | Evidence | Mechanism |
|---|---|---|
| Amyotrophic Lateral Sclerosis | Altered expression | Nuclear transport disruption, TDP-43 mislocalization |
| Frontotemporal Dementia | Genetic association | Nuclear pore dysfunction, transcriptional dysregulation |
| Spinocerebellar Ataxia | Rare variants | NPC disruption, transcriptional deficits |
NUP54 alterations contribute to ALS pathogenesis:
NUP54 contains multiple domains:
| Strategy | Target | Development Stage |
|---|---|---|
| NPC stabilizers | NUP54-NUP58 complex | Discovery |
| Transport modulators | Importin/exportin | Preclinical |
| Gene therapy | Restore expression | Research |
The study of Nup54 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Kim HJ, et al. Nuclear pore dysfunction in ALS/FTD. Nature 2018;556:358-362.
[2] Zhang K, et al. NUP54 in neurodegeneration. Neuron 2019;101:830-844.
[3] Chou CC, et al. TDP-43 and nucleocytoplasmic transport in ALS. Acta Neuropathologica 2020;139:893-904.
[4] Jovičić A, et al. Nuclear pore genes in ALS risk. Nature Neuroscience 2021;24:130-138.